secwatch.observer — SEC 8-K summary
======================================

Issuer:     WINDTREE THERAPEUTICS INC /DE/ (WINT)
CIK:        0000946486
Form:       8-K
Filed at:   2025-03-24T23:59:59+00:00
Accession:  0001437749-25-008981
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.03, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Windtree raises $250K via secured notes, licenses Phexxi supply rights, regains Nasdaq compliance
--------------------------------------------------------------------------------

- Issued $312,500 principal in senior secured notes at 10% interest, due March 2026, with 20% OID; net proceeds $250,000.
- Entered license and supply agreement with Evofem to manufacture and supply Phexxi outside the U.S. for an initial three-year term.
- Regained compliance with Nasdaq minimum bid price rule (closing bid >$1.00 since Feb 21, 2025); subject to panel monitor until March 20, 2026.
- Notes secured by first-priority lien on all assets; mandatory redemption of 30% of equity line proceeds if equity line is used.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946486/000143774925008981/0001437749-25-008981-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946486/000143774925008981/wint20250323_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-008981

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer